In a recent publication, Bulkamid injections for SUI were found to be efficacious, safe and durable. The January 2021 issue of Neurourology and Urodynamics reports 7-year outcomes in 388 patients. Positive results of this minimally invasive option include 81% of patients being satisfied with no...
Based on input from many patients Axonics redesigned their recharging belt to optimize patient experience. The curved design offers improved ergonomic fit (Shown Below) and offers an enhanced charging experience. IPG placement moved from a lateral pocket placement to a medial pocket placement based on...
Sansum Urology will participate in the Axonics ARTISTRY study. This study will be a post-market clinical registry study to collect and analyze real-world data of patients treated with the Axonics r-SNM® System. It will be a prospective, multicenter registry which aims to enroll up to 300...
The ability to have a full body MRI with an SNM device only became available in November 2019 with Axonics followed by Medtronic in August 2020. MRIs are a common imaging modality with 1 in 9 U.S. adults obtaining an MRI yearly and over 40%...
Results from the ARTISAN pivotal trial published in the journal Neuromodulation revealed 87% of fecal incontinence patients implanted with the Axonics device had at least a 50% reduction in FI episodes at 1 month. 92% were responders at 6 months post-implant. Weekly FI episodes decreased...